๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Rituximab in severe, treatment-refractory interstitial lung disease

โœ Scribed by Keir, Gregory J.; Maher, Toby M.; Ming, Damien; Abdullah, Reza; de Lauretis, Angelo; Wickremasinghe, M.; Nicholson, Andrew G.; Hansell, David M.; Wells, Athol U.; Renzoni, Elisabetta A.

Book ID
121727667
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
274 KB
Volume
19
Category
Article
ISSN
1323-7799

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Rituximab-induced interstitial lung dise
Rituximab-induced interstitial lung disease
โœ Stephanie A. Wagner; Apurva C. Mehta; Damian A. Laber ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 86 KB ๐Ÿ‘ 2 views

## Abstract The aim of this study is to characterize rituximabโ€induced interstitial lung disease (Rโ€ILD). The information on all reported cases of Rโ€ILD was reviewed. This analysis focused on patient characteristics, underlying disease, rituximab dosing schedule, and Rโ€ILD characteristicโ€like sympt